Systemic vascular inflammation plays multiple maladaptive roles which contribute to the
progression and destabilization of atherosclerotic cardiovascular disease (ASCVD). These …

This article has been copublished in the April issue of Clinical Chemistry (Volume 53,
Number 4, 2007). 1 Brigham and Women's Hospital, Harvard University, Boston, MA. 2 …

Background Since inflammation is believed to have a role in the pathogenesis of
cardiovascular events, measurement of markers of inflammation has been proposed as a …

Background—Interleukin-6 (IL-6) plays a central role in inflammation and tissue injury.
However, epidemiological data evaluating the role of IL-6 in atherogenesis are sparse …

2998 dilated cardiomyopathy and mild to moderate chronic CHF often have EFs
considerably lower than this and are not in shock. 12 These observations highlight the role …

Angiotensin II type 1 (AT1) receptor activation as well as proinflammatory cytokines such as
interleukin-6 (IL-6) are involved in the development and progression of atherosclerosis. The …

High-sensitivity C-reactive protein (hsCRP) is a marker of inflammation that predicts incident
myocardial infarction, stroke, peripheral arterial disease, and sudden cardiac death among …

Markers of myocyte necrosis such as cardiac troponin or creatine kinase-myocardial band
are invaluable tools for risk stratification among patients presenting with acute coronary …

Atherosclerosis is nowadays generally accepted as an inflammatory disease. It is known that
local inflammation occurs in the formation the plaques, as macrophages and other immuno …

Background The role of inflammation in patients with coronary artery disease is emerging.
We sought to assess the profile and outcomes of patients with a clinical syndrome of severe …